Conference Call with Quick Heal Technologies Management and Analysts on Q4FY23 Performance and Outlook. Listen to the full earnings transcript.
Conference Call with Quick Heal Technologies Management and Analysts on Q3FY23 Performance and Outlook. Listen to the full earnings transcript.
IT software products company Quick Heal Technologies announced Q2FY23 results: Q2FY23: Revenue at Rs 101 crore EBIDTA at Rs 28.4 crore PAT at Rs 22.2 crore H1FY23 Revenue at Rs162 crore EBITDA at Rs 29.4 crore PAT at Rs 22.3 crore Dr. Kailash Katkar, Managing Director and Chief Executive Officer, Quick Heal Technologies Limited, said, “We continue to deliver strong growth in our revenues in the enterprise segment. Q2 marks 9th straight quarter delivering YoY growth for the Enterprise segment. This solidifies our belief in the business we incubated from scratch years ago and has crossed Rs 100 crore revenues in TTM basis. We have taken focussed initiatives and interventions towards our consumer segment which is degrowing at 11% to bring it back to the growth path. We have been investing heavily into our R&D; and S&M; for achieving our vision of growing multifold in the years to come,” he added. Mr. Navin Sharma, Chief Financial Officer, Quick Heal Technologies Limited, said, “The need for cybersecurity is fundamentally increasing owing to the developments happening across the globe. We are overlooking bright opportunities and investing heavily in R&D; and S&M; to address the core and evolving needs of the customers. R&D; investments for the quarter stands at 30% while the S&M; stands at 25%. Our balance sheet remains strong with zero debt and cash and cash equivalents of Rs 338 crore as on 30th September 2022. We are committed to driving shareholder value by growing profitability across both of our segments and driving solid Unlevered Cash Flow and constantly rewarding our shareholders though buyback and dividend distribution programs.” Result PDF